Adc Therapeutics Sa earnings were -$149.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ADCT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$38.6M, up 25.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADCT reported annual earnings of -$157.8M, with -34.2% growth.
Adc Therapeutics Sa Earnings Reports & History FAQ
What were Adc Therapeutics Sa's earnings last quarter?
On ADCT's earnings call on Invalid Date, Adc Therapeutics Sa (NYSE: ADCT) reported Q1 2025 earnings per share (EPS) of -$0.36, up 35.71% year over year. Total ADCT earnings for the quarter were -$38.60 million. In the same quarter last year, Adc Therapeutics Sa's earnings per share (EPS) was -$0.56.
Is Adc Therapeutics Sa profitable or losing money?
As of the last Adc Therapeutics Sa earnings report, Adc Therapeutics Sa is currently losing money. Adc Therapeutics Sa's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$149.84 million, a 34.07% decrease year over year.
What was ADCT's earnings growth in the past year?
As of Adc Therapeutics Sa's earnings date in Invalid Date, Adc Therapeutics Sa's earnings has grown year over year. ADCT earnings in the past year totalled -$149.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.